Novo Nordisk says trial with next-gen drug in diabetics shows 15.7% weight loss
Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...
Hosted on MSN2d
10 of the biggest weight loss myths, according to an obesity medicine expert
One quick online search or scroll through social media and you'll find an endless amount of weight loss advice. But it's hard ...
Eating Less of This Food Leads to Weight Loss in Just 8 Weeks
A new study breaks down exactly how to stop eating ultra-processed foods in eight weeks. Here's what it found and what ...
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...
New Discovery Promises Weight Loss Without Ozempic's Side Effects
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...
The Best High-Fat Foods for Weight Loss, Recommended by Dietitians
Avocados, fatty fish, salad dressing, nuts and yogurt are high-fat foods that can support weight loss. Fat provides energy ...
Newspoint on MSN2d
Obesity No More: Learn What to Eat and What to Avoid for Sustainable Weight Loss
Obesity is a complex health condition that requires a balanced approach to nutrition, lifestyle changes, and, in some cases, ...
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating ...
Popular weight-loss drugs get cheaper: Novo Nordisk and Eli Lilly cut prices
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Medscape6d
Most Doctors Fail to Discuss Weight Loss When Caring for Patients With Obesity and Asthma
Obesity worsens asthma severity and responses to medication, yet most doctors fail to address weight management with these ...
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...